Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications
Martyna Lica-Miler, Karol Miler, Dorota Kostrzewa-Nowak, Andrzej Ciechanowicz, Andrzej Brodkiewicz, Jacek Różański, Joanna Stępniewska · 2026
Read Vaptans: A Narrative Review of Pharmacokinetics, Pharmacogenetics, and Clinical Applications by Martyna Lica-Miler, Karol Miler, Dorota Kostrzewa-Nowak, Andrzej Ciechanowicz, Andrzej Brodkiewicz, Jacek Różański, Joanna Stępniewska (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13464911.txt.
Description
Lica-Miler and colleagues wrote a 2026 review of vaptans, a class of water-balance drugs. These drugs block a hormone signal that tells the kidneys to hold water. The review traces how the drugs grew from lab-made copies to pills taken by mouth. It covers tolvaptan, conivaptan, and mozavaptan in depth.
Tolvaptan stands out as a drug that slows polycystic kidney disease, not just treats symptoms. Vaptans also help when blood sodium drops too low from hormone imbalance. Gene differences help explain why patients respond in uneven ways to the same dose. Two gene variants get close attention for their effects on drug handling. The authors close with safety checks doctors should run during treatment. The review also tracks how the body takes in, breaks down, and clears each drug.
Catalog record
| CREATOR | Martyna Lica-Miler, Karol Miler, Dorota Kostrzewa-Nowak, Andrzej Ciechanowicz, Andrzej Brodkiewicz, Jacek Różański, Joanna Stępniewska |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |